Comparison Of Efficacy And Safety Profile Of Empagliflozin Versus Dapagliflozin As Add On Therapy In Type 2 Diabetic Patients.
Year: 2021
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: Mazhar Hussain, Moazzam Atif, Muhammad Babar, Lubna Akhtar
Institution: Shaikh Zayed Medical College and Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4210948531